PATENT CLAIM ANALYSIS

Application Number: 15980325
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "136100"]

Abstract:
The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-17A and IL-17F. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. The present invention includes antibodies that bind both IL-17A and IL-17F, hybridomas that produce the antibodies, and methods of using the same in inflammation.

Claim (Index 4):
A method of producing a cross-reactive monoclonal antibody encoded by the DNA segment in the expression vector of  claim 2  comprising:\n culturing a host cell comprising said vector under conditions wherein the monoclonal antibody is expressed; and \n recovering the monoclonal antibody.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.65789
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13910311', '13539534', '12832311', '11741189', '15208202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6881102284067743
- 35 USC 102 Novelty (BERT): 0.4813278139592111
- Combined Prediction Score: 0.667431986962018
- Mean Citation Score: 251.382922
- Max Citation Score: 253.02383
- Similarity Product: 251.9212291744936

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test